MedTrace Logo

PACEPro - Mood Management Pilot

NCT00416221 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2011-08-18

No results posted yet for this study

Summary

Researchers at the University of California at San Diego (UCSD) are conducting a 12-week study to test the PACEPRO program. This program is designed to reduce depression by providing:

Lexapro, an antidepressant medicine…Learn More Physical activity information and pedometer Mood management skills and a Mood Mastery Guide Personalized support from a Family Nurse Practitioner

Conditions

Interventions

DRUG

Lexapro, an antidepressant medicine

BEHAVIORAL

Physical Activity

BEHAVIORAL

Mood Management Skills

BEHAVIORAL

Personalized support from a Family Nurse Practitioner

Sponsors & Collaborators

Principal Investigators

  • Kevin Patrick, MD, MS · UCSD

  • Catherine Pearson-Bennett, MSN, RN · UCSD

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Completion
2007-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00416221 on ClinicalTrials.gov